The landscape of dementia prognosis has developed significantly with the arrival of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology a long time in advance of symptoms emerge. Even though these technological innovations signify impressive development in und